PRESS RELEASE published on 06/10/2025 at 10:06, 1 year 2 months ago Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION) covering the recent challenges and opportunities in the biotech sector, including market volatility and long-term outlook Edison Market Volatility Biotech Sector BB Biotech Long-term Outlook
BRIEF published on 04/25/2025 at 07:05, 1 year 3 months ago BB Biotech AG Reports CHF 241 Million Net Loss for Q1 2025 Drug Development Net Loss Investment Portfolio Interim Report BB Biotech
BRIEF published on 04/25/2025 at 07:05, 1 year 3 months ago BB Biotech AG annonce une perte nette de 241 millions de francs suisses au premier trimestre 2025 Perte Nette Portefeuille D'investissement Développement De Médicaments BB Biotech Rapport Intermédiaire
BRIEF published on 04/25/2025 at 07:05, 1 year 3 months ago BB Biotech Q1 2025: Portfolio Adjustments Amid Volatile Market Market Volatility Investment Portfolio Biotech Sector BB Biotech FDA Approvals
BRIEF published on 04/25/2025 at 07:05, 1 year 3 months ago BB Biotech T1 2025 : ajustements de portefeuille dans un contexte de marché volatil Volatilité Du Marché Portefeuille D'investissement BB Biotech Secteur Biotechnologique Approbations De La FDA
PRESS RELEASE published on 04/25/2025 at 07:00, 1 year 3 months ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 1 year 3 months ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 1 year 4 months ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
BRIEF published on 03/19/2025 at 17:50, 1 year 4 months ago Les actionnaires de BB Biotech AG approuvent le dividende et réélisent le conseil d'administration Dividende Stratégie D'investissement Réélection Du Conseil D'administration BB Biotech Assemblée Générale Annuelle 2025
PRESS RELEASE published on 03/19/2025 at 17:45, 1 year 4 months ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share Shareholders at BB Biotech AG’s AGM approve dividend of CHF 1.80 per share and all board proposals. Re-elected board members for another term Shareholders Dividend AGM BB Biotech AG Board Proposals
Published on 08/13/2026 at 09:05, 1 hour 6 minutes ago Battery X Metals Appoints Lithium-Ion Battery and Electric Vehicle Entrepreneur William Fan as President to Advance Development of Its Patent-Pending Lithium-Ion Battery Rebalancing Technology Platform and Corporate Growth Initiatives
Published on 08/13/2026 at 08:00, 2 hours 11 minutes ago Battery X Metals Maintains Y Lithium Project Claims in Good Standing and Evaluates Phase I Exploration Program
Published on 08/13/2026 at 07:30, 2 hours 41 minutes ago Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
Published on 08/12/2026 at 23:30, 10 hours 41 minutes ago CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/13/2026 at 10:05, 5 minutes ago Thunes Expands Web3 Infrastructure with EURC to Enable Instant Euro Treasury Funding
Published on 08/13/2026 at 10:00, 11 minutes ago BENO Holding AG Acquires and Leases Light Industrial Property in the Nuremberg Metropolitan Area
Published on 08/13/2026 at 09:52, 18 minutes ago Gledhow Investments plc: £400,000 Subscription, Strategic Repositioning and Proposed Board Appointments
Published on 08/13/2026 at 09:17, 53 minutes ago EQS-Adhoc: InTiCa Systems SE: InTiCa Systems SE resolves to prepare the change from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Published on 08/11/2026 at 17:45, 1 day 16 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 16 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 16 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 16 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
